Lexpert US Guides

Litigation 2016

The Lexpert Guides to the Leading US/Canada Cross-Border Corporate and Litigation Lawyers in Canada profiles leading business lawyers and features articles for attorneys and in-house counsel in the US about business law issues in Canada.

Issue link: https://digital.carswellmedia.com/i/752493

Contents of this Issue

Navigation

Page 68 of 99

LEXPERT • December 2016 | www.lexpert.ca | 69 INTELLECTUAL PROPERTY Stratton, Bruce W., DLA Piper (Canada) LLP Toronto - (416) 862-3382 - bruce.stratton@dlapiper.com Practices in the area of intellectual property law. Member of the LSUC, CBA, IPIC (Fellow), iTechLaw, AIPLA, e Advocates' Society, ABA. Education: BSc (computing science, first class), 1981, Queen's Uni- versity. LLB, 1985, University of Toronto. Trial counsel in Federal Court, appellate counsel in Federal Court of Appeal and in the Supreme Court of Canada on patent and trade-mark matters. Author of the Annotated Patent Act (looseleaf service, Carswell) and co-author of the "Computer-Related Disputes" chapter in Intel- lectual Property Disputes: Resolutions and Remedies (looseleaf service, Carswell). Has written for and presented to numerous professional associations, including CBA, AIPLA, IPIC, NYSBA, iTechLaw, IT Can, Univer- sity of Toronto, Osgoode Hall Law School and the National Judicial Institute. Topics include: Open Source Soware, Non-Practicing Entities, Cross-Examination of Soware Experts, Effective Opening Statements, Developments in International Patent Law. Registered Patent Agent and Trade-mark Agent. Admitted to the Ontario Bar in 1987. Shaughnessy, Andrew M., Torys LLP Toronto - (416) 865-8171 - ashaughnessy@torys.com Practice focuses on IP litigation and dispute resolution, and Federal Court practice. Has represented a wide variety of clients in complex patent and trade-mark infringement and related litigation. Has been an advocate before the Supreme Court of Canada, the Federal Court of Canada, Federal Court of Appeal, Ontario Supe- rior Court of Justice, Court of Appeal for Ontario, and specialized tribunals such as the Trademarks Opposi- tion Board. Serves as one of the Canadian Bar Association's Intellectual Property section representatives on the Federal Court IP Users' Committee. Well-known IP and advocacy speaker, instructor and author. Adjunct lecturer at the University of Toronto Faculty of Law, where he oversees participation in the Harold G. Fox Intellectual Property Moot. Ontario Bar, 1993. LLB, 1991, Queen's University. Wilcox, Peter R., Belmore Neidrauer LLP Toronto - (416) 863-3363 - peter.wilcox@belmorelaw.com Peter Wilcox has over 20 years of experience litigating complex intellectual property cases at trial and on appeal. He has particular experience litigating cases for the pharmaceutical and biotechnology industries and also has experience litigating cases involving medical devices and oil field technology. Recently, Wilcox has been lead counsel for Bayer, Alcon, Janssen, Takeda, Eli Lilly, Pfizer and National Oilwell Varco. He is consis- tently recognized by his peers and clients as a leader in intellectual property litigation in such publications as Chambers, Who's Who Legal, IAM Patent, Lexpert® and Best Lawyers. Wilcox is currently the President of the Intellectual Property Institute of Canada. Creber, Anthony (Tony), Gowling WLG Ottawa - (613) 786-0140 - anthony.creber@gowlingwlg.com Tony Creber is a senior partner with Gowlings and is its senior IP litigation counsel. Creber's primary focus has been in chemical, biotech and pharmaceutical patent litigation. His practice includes trade-mark litiga- tion, regulatory issues and advising on IP life cycle. Creber has been consistently recognized by e Best Lawyers in Canada and Lexpert® and other similar directories as a leading lawyer in litigation, IP and bio- technology. He regularly appears in the Federal Court as well as the Supreme Court of Canada on patent matters, including questions of patentability of life forms, patent licensing and the infringement of biotech patents. Important cases he has appeared in include the SCC decisions in Schmeiser and Plavix. Most recently he represented Novartis in protecting its patent on Gleevec and Biotech Canada in an access-to-information case before the SCC, which corrected a restrictive interpretation of the trade secret exemption. Creber won the coveted "Patent Case of 2009," "Practitioner of Year, 2014" and "Milestone Case of 2014" awards given by Managing Intellectual Property.

Articles in this issue

Links on this page

Archives of this issue

view archives of Lexpert US Guides - Litigation 2016